3D Systems Corporation announced today that it named Kevin McAlea Executive Vice-President & Chief Operating Officer for its healthcare business. In this new role, McAlea will be responsible for developing and executing 3DS’ healthcare growth strategy, integrating recent acquisitions into a cohesive and synergistic suite of products and services, and scaling the company’s rapidly developing healthcare category.
“I am delighted that Kevin McAlea is at the helm of our healthcare business,” said Avi Reichental, President and Chief Executive Officer, 3DS. “With more than two decades of 3D global business and technology experience, Kevin is uniquely qualified to lead our fast growing healthcare business.”
Since joining the company in 2001, as part of the DTM acquisition, McAlea has held several senior leadership roles at 3D Systems. Most recently, he served as 3DS’ Chief Impact Officer and oversaw the successful acquisition, integration and commercialization of 3D Systems’ direct metals printer line, following the company’s acquisition of Phenix Systems and Layerwise. Before that, McAlea led the development and sales of 3DS’ entire portfolio of production printers.
“Kevin takes the reins of our healthcare operations at an opportune moment,” continued Reichental. “I have full confidence that he will be able to leverage our recent acquisitions of Medical Modeling, Simbionix and Layerwise, as well as our self-developed medical and dental services, to extend our leadership position and first mover advantage in this open-ended vertical.”
